Ozempic vs Wegovy: What Is the Difference?

Understanding what each medicine actually is can help you have a more informed conversation with your prescriber. Here is a factual, neutral overview of the medicines most commonly mentioned alongside Wegovy.

Ozempic vs Wegovy

Ozempic and Wegovy both contain semaglutide, a GLP-1 receptor agonist that acts on appetite-regulating pathways and slows gastric emptying. The key differences are in licensed indication and available dose strengths. Ozempic is licensed for type 2 diabetes management; Wegovy is licensed specifically for chronic weight management. Wegovy reaches a higher maintenance dose (up to 2.4 mg weekly). Because they share an active substance, people sometimes ask about one when they have been prescribed the other — but switching or substituting is a decision for a prescriber, not a self-directed choice.

Mounjaro (Tirzepatide) vs Wegovy

Mounjaro contains tirzepatide, a dual GIP and GLP-1 receptor agonist — meaning it acts on two appetite-related pathways rather than one. It is a distinct medicine from semaglutide. Both are once-weekly injectables and both are prescription-only. For a detailed look at how these two medicines differ mechanistically and what that means in practice, see our page on Mounjaro vs Wegovy or the broader Wegovy and Mounjaro comparison hub. The right choice between them is one your prescriber makes based on your full medical history.

Saxenda vs Wegovy

Saxenda contains liraglutide, an earlier GLP-1 receptor agonist administered as a daily (not weekly) injection. Wegovy (semaglutide) is a once-weekly injection. Both are prescription-only weight-management medicines; they are not the same drug and are not interchangeable.

Rybelsus vs Wegovy

Rybelsus also contains semaglutide — the same active substance as Wegovy — but is taken as a daily oral tablet rather than a weekly injection. It is licensed for type 2 diabetes. Whether it is appropriate for weight management in a given individual is a decision for a prescriber.

Orlistat and Xenical vs Wegovy

Orlistat (sold under the brand name Xenical, among others) works by a completely different mechanism — it reduces fat absorption in the gut rather than acting on appetite pathways. It is taken orally with meals. It is an older medicine with a different side-effect profile. Comparing it to Wegovy is a conversation to have with a prescriber, who can weigh up what is appropriate for your circumstances.

Mysimba vs Wegovy

Mysimba contains naltrexone and bupropion, two non-GLP-1 active substances that act on reward and appetite pathways in the brain. It is a prescription-only oral tablet. It is mechanistically unrelated to semaglutide or tirzepatide.

Retatrutide — Still in Development

Retatrutide is an investigational medicine (a triple GIP, GLP-1, and glucagon receptor agonist) that, at the time of writing, has not received regulatory approval as a licensed medicine. It is not currently available by prescription.

A Note on "Nevolat"

"Nevolat" does not correspond to a recognised licensed medicine name at the time of writing. If you have seen this term, check with your prescriber or pharmacist to clarify what is being referred to.

For a side-by-side look at how Wegovy and Mounjaro compare on side effects specifically, the page on Wegovy vs Mounjaro side effects covers that in more detail. You may also find the related discussion on Manjaro vs Wegovy useful if you have seen that spelling in your research.

GLP Trackr is built for people already prescribed Mounjaro or Wegovy (and by extension, any semaglutide or tirzepatide medicine their prescriber has put them on). The app does not tell you which medicine to take — that decision belongs with your prescriber — but once you are prescribed, it helps you stay consistent and understand your own journey.

The most relevant feature for someone navigating a new prescription or switching between medicines is the dose and injection logging tool. Every weekly shot — dose strength, date, time, and injection site — is recorded in one place, so there is never any ambiguity about where you are in your schedule. If your prescriber adjusts your dose or you move between medicines, you simply update what you log; the history stays intact.

Alongside that, the side-effect tracker lets you note how you feel after each dose and spot patterns over time — which is especially useful in the early weeks of a new medicine or after a dose change. That log becomes something concrete and useful to bring to your next prescriber appointment, rather than trying to recall how you felt three weeks ago.

Any decision about your dose, your medicine, or whether to switch should always be made with your prescriber — they know your full medical picture. GLP Trackr helps you record the information that makes those conversations more productive; it is not a substitute for clinical guidance.

If you are already prescribed and want to keep your journey properly logged, GLP Trackr is free to start on the App Store or Google Play — there is a 7-day trial so you can see whether it works for you before committing.